Company Summary

1200 Pharma uses breakthrough medicinal chemistry technology from Caltech and proprietary biomarker-driven assays from UCLA to discover novel drugs with enhanced properties at a fraction of the industry average cost and timeline.

Year Founded:  2018

Key Executives:
David Licata, CEO

Location:  Pasadena, CA

Company Status:  Private

Year Invested:  2017

Investment Status:  Current

Board Members:
Paul Becker (Observer)